Tags: Drug.

Glembatumumab vedotin (also known as CDX-011 and CR011-vcMMAE) is an antibody-drug conjugate (ADC) that targets cancer cells expressing transmembrane glycoprotein NMB (GPNMB).In May 2010 the U.S FDA granted Fast Track designation to CDX-011 for the treatment of advanced refractory or resistant GPNMB-expressing breast cancer.

ATC prefix
none
CAS number
1020264-78-1
CAS supplemental
(glembatumumab)

Loading...

This page contains content from the copyrighted Wikipedia article "Glembatumumab vedotin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.